Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Celgene
Celgene
Newsletters
Bristol Myers Squibb and Celgene got a beating in Congress on drug prices—but only Congress can fix the problem
By
Sy Mukherjee
October 1, 2020
Newsletters
The FDA Went on an Epic Drug Approval Binge This Week: Brainstorm Health
By
Sy Mukherjee
August 16, 2019
Health
Bristol-Myers Squibb Loses $6 Billion in Value on Celgene Deal Setback: Brainstorm Health
By
Sy Mukherjee
June 24, 2019
Celgene Boosted Price of Top Cancer Drug on Day of Mega-Deal
By
Bloomberg
January 4, 2019
Bristol-Myers Is Buying Celgene for $74 Billion in One of the Largest Big Pharma Mergers Ever
By
Bloomberg
January 3, 2019
Russian Drugmaker Granted License to Produce Celgene Copycat
By
McKenna Moore
July 11, 2018
Health
The FDA Is Naming and Shaming Companies Accused of Blocking Cheap Generic Drugs
By
Sy Mukherjee
May 17, 2018
Health
Why Analysts Are Calling Celgene’s $9 Billion Juno Acquisition a ‘Smart’ Biotech Deal
By
Sy Mukherjee
January 22, 2018
Finance
U.S. Biotech Firm Celgene to Buy Impact Biomedicines for up to $7 Billion
By
Reuters
January 8, 2018
Health
This 31-Year-Old CEO Is Snapping Up Drug Industry Veterans Left and Right
By
Sy Mukherjee
July 10, 2017
Health
Drug and Device Makers Shelled Out $8 Billion to Doctors and Hospitals Last Year
By
Sy Mukherjee
July 6, 2017
Finance
The 3 Best Health Care and Pharma Stocks for 2017—Whatever Happens to Obamacare
By
Jen Wieczner
December 1, 2016
Health
AI Takes On Drug Safety
By
Sy Mukherjee
and
Clifton Leaf
November 1, 2016
Health
Here’s the Surprising Reason IBM Is Partnering With Celgene
By
Clifton Leaf
November 1, 2016
Health
Whistleblower Claims Celgene Colluded With Charities to Drive Profits
By
Sy Mukherjee
August 1, 2016
Most Popular
Retail
Trump just declared Christmas Eve a national holiday. Here’s what’s open and closed
By
Dave Smith
Personal Finance
Trump turns government into giant debt collector with threat to garnish wages on millions of Americans in default on...
By
Annie Ma
and
The Associated Press
Personal Finance
Financial experts warn future winner of the $1.7 billion Powerball: Don't make these common money mistakes
By
Ashley Lutz